throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`SAMSUNG BIOEPIS CO., LTD.
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.
`Patent Owner.
`
`Patent No. 11,253,572
`
`_______________
`
`Inter Partes Review No. IPR2023-00884
`____________________________________________________________
`
`PATENT OWNER’S MOTION FOR PRO HAC VICE ADMISSION OF
`KIRA A. DAVIS UNDER 37 C.F.R. § 42.10(c)
`
`

`

`IPR2023-00884
`
`I.
`
`Relief Requested
`
`Pursuant to 37 C.F.R. § 42.10, Patent Owner Regeneron Pharmaceuticals,
`
`Inc., requests that the Board admit Kira A. Davis pro hac vice in this proceeding.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`
`In accordance with 37 C.F.R. § 42.10(c), the Board may recognize counsel
`
`pro hac vice during a proceeding, subject to the conditions set forth therein, and
`
`any others that the Board may impose. Patent Owner sets forth these facts in
`
`support of this motion:
`
`1.
`
`The undersigned contacted counsel for Petitioner (Quinn Emanuel
`
`Urquhart & Sullivan LLP), who indicated that Petitioner did not plan to oppose
`
`Ms. Davis’s admission pro hac vice.
`
`2.
`
`Lead counsel for Patent Owner, Regeneron Pharmaceuticals, Inc.,
`
`Adam Brausa, and Backup counsel, Rebecca Weires are registered practitioners.
`
`3.
`
`Kira A. Davis is an experienced litigator and has established
`
`familiarity with the subject matter at issue in this proceeding. Accompanying this
`
`motion is Exhibit 2060, the Declaration of Kira A. Davis in Support of this Motion
`
`for Admission Pro Hac Vice (“Davis Decl.”). In her declaration, Ms. Davis attests,
`
`among other things, that she is a member in good standing of the bars of the states
`
`of California and New York. Davis Decl. ¶¶ 1-2. Ms. Davis has never been
`
`subject to suspensions or disbarments from practice, nor had applications for
`
`1
`
`

`

`IPR2023-00884
`
`admission to practice denied, nor been subject to any sanctions or contempt
`
`citations by any court or administrative body. Id. ¶¶ 3-5.
`
`4.
`
`Ms. Davis has approximately 12 years of experience litigating patent
`
`cases involving biotechnology. Davis Decl. ¶ 9. As is relevant to this matter,
`
`during the past 12 years, Ms. Davis has litigated a number of cases involving
`
`biologic therapeutics, including fusion proteins and antibodies, as well as cases
`
`relating to methods of treatment using the same. Id. In addition, Ms. Davis’s
`
`familiarity with the subject matter at issue in this proceeding is demonstrated by
`
`her review of the ’572 Patent, all cited prior art, and the IPR petition in this matter.
`
`Davis Decl. ¶ 10.
`
`5.
`
`In her declaration, Ms. Davis also attests to her admission to practice
`
`s§42.10(c) and Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper
`
`7 (PTAB Oct. 15, 2013). See Davis Decl. ¶¶ 1-10.
`
`III. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully request that the Board
`
`admit Kira A. Davis pro hac vice in this proceeding.
`
`2
`
`

`

`IPR2023-00884
`
`Date: December 21, 2023
`
`Respectfully Submitted,
`
`By: /Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, California 94105
`Tel: (415) 268-6053
`ABrausa@mofo.com
`
`Counsel for Patent Owner
`
`3
`
`

`

`IPR2023-00884
`
`Certificate of Service (37 C.F.R. § 42.6(e)(4))
`
`I hereby certify that the attached PATENT OWNER’S MOTION FOR PRO
`
`HAC VICE ADMISSION OF KIRA A. DAVIS UNDER 37 C.F.R. § 42.10(c) and
`
`THE SUPPORTING DECLARATION OF KIRA A. DAVIS, were served on the
`
`date listed below via electronic mail upon the following counsel of record for
`
`Petitioner.
`
`Raymond N. Nimrod (Reg. No. 31,987)
`Matthew A. Traupman (Reg. No. 50,832)
`Landon Andrew Smith (Reg. No. 79,248)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`51 Madison Ave., 22nd Floor
`New York, NY 10010
`Email: raynimrod@quinnemanuel.com
`Email: matthewtraupman@quinnemanuel.com
`Email: landonsmith@quinnemanuel.com
`Email: qe-samsungbioepis@quinnemanuel.com
`
`Dated: December 21, 2023
`
`/Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`
`4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket